TY - JOUR
T1 - Recognizing and analyzing variability in amyloid formation kinetics
T2 - Simulation and statistical methods
AU - Hall, Damien
AU - Zhao, Ran
AU - So, Masatomo
AU - Adachi, Masayuki
AU - Rivas, Germán
AU - Carver, John A.
AU - Goto, Yuji
N1 - Publisher Copyright:
© 2016
PY - 2016/10/1
Y1 - 2016/10/1
N2 - We examine the phenomenon of variability in the kinetics of amyloid formation and detail methods for its simulation, identification and analysis. Simulated data, reflecting intrinsic variability, were produced using rate constants, randomly sampled from a pre-defined distribution, as parameters in an irreversible nucleation-growth kinetic model. Simulated kinetic traces were reduced in complexity through description in terms of three characteristic parameters. Practical methods for assessing convergence of the reduced parameter distributions were introduced and a bootstrap procedure was applied to determine convergence for different levels of intrinsic variation. Statistical methods for assessing the significance of shifts in parameter distributions, relating to either change in parameter mean or distribution shape, were tested. Robust methods for analyzing and interpreting kinetic data possessing significant intrinsic variance will allow greater scrutiny of the effects of anti-amyloid compounds in drug trials.
AB - We examine the phenomenon of variability in the kinetics of amyloid formation and detail methods for its simulation, identification and analysis. Simulated data, reflecting intrinsic variability, were produced using rate constants, randomly sampled from a pre-defined distribution, as parameters in an irreversible nucleation-growth kinetic model. Simulated kinetic traces were reduced in complexity through description in terms of three characteristic parameters. Practical methods for assessing convergence of the reduced parameter distributions were introduced and a bootstrap procedure was applied to determine convergence for different levels of intrinsic variation. Statistical methods for assessing the significance of shifts in parameter distributions, relating to either change in parameter mean or distribution shape, were tested. Robust methods for analyzing and interpreting kinetic data possessing significant intrinsic variance will allow greater scrutiny of the effects of anti-amyloid compounds in drug trials.
KW - Aggregation assay
KW - Amyloid
KW - Anti-amyloid drug screening
KW - Statistical significance
UR - http://www.scopus.com/inward/record.url?scp=84979294102&partnerID=8YFLogxK
U2 - 10.1016/j.ab.2016.07.013
DO - 10.1016/j.ab.2016.07.013
M3 - Article
SN - 0003-2697
VL - 510
SP - 56
EP - 71
JO - Analytical Biochemistry
JF - Analytical Biochemistry
ER -